AGILON HEALTH, INC.

Lobbying for AGILON HEALTH, INC. · Health care provider

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 19, 2026

Expenses

$90,000

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

Texas

Official filing document

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Medicare/Medicaid

Issues related to value-based health care, including Medicare Advantage (MA) and ACO models; Medicare Shared Savings Program (MSSP); LEAD Model; MA data sharing; the Patients First Act (HR 9693), including APM bonus payments; HR 8129 full-risk ACO legislation; and related CMS innovation and payment model activities through CMMI.

Bills named in this filing 2

H.R. 9693
Patients First Act of 2026
H.R. 8129
To amend title XVIII of the Social Security Act to establish a full risk ACO program.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.